NURL — Neural Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$1.33m
- CA$1.17m
Annual cashflow statement for Neural Therapeutics, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2022 July 31st | 2023 July 31st | 2024 July 31st | 2025 July 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -1.82 | -1.08 | -0.666 | -1.03 |
| Non-Cash Items | 1.08 | -0.011 | 0.047 | 0.526 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.141 | 0.56 | 0.299 | 0.184 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -0.602 | -0.527 | -0.32 | -0.315 |
| Financing Cash Flow Items | 0.181 | 0 | -0.013 | -0.038 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.973 | 0.428 | 0.113 | 0.414 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.372 | -0.099 | -0.207 | 0.099 |